Company Search:
Advanced Search
Sponsored Links
Pulmatrix Inc Company Snapshot
Pulmatrix Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Pulmatrix Inc with three other companies in this sector in the United States: Cyclacel Pharmaceuticals, Inc. (2018 sales of $150,000.00 of which 100% was Pharmaceutical Products), TG Therapeutics Inc ($152,000.00 of which 100% was License Revenue), and Alterity Therapeutics Ltd ($155,604.07 ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Pulmatrix Inc
  Stock Performance Chart for Pulmatrix Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/24/2020): 1.62
(Figures in U.S. Dollars)
1 Week -0.6%   13 Weeks 92.9%  
4 Weeks 131.4%   52 Weeks -22.9%  
Pulmatrix Inc Key Data:
  Ticker: PULM Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 153,000
(Year Ending Jan 2019).
Employees: 6
  Currency: U.S. Dollars Market Cap: 32,391,187
  Fiscal Yr Ends: December Shares Outstanding: 19,994,560
  Share Type: Common Closely Held Shares: 33,886
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.